AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

Completed · Not applicable

Conditions studied: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Bradycardia, Tachycardia

In brief

The study is a prospective single-arm multicenter clinical trial. Adult patients will be consented and enrolled in an outpatient cardiology office or Arrhythmia Clinics.

Key facts

Study ID

NCT06123130

Run by

HeartBeam, Inc.

People needed

198

Starts

2024-03-13

Expected to finish

2024-06-20

Last updated by the study team

2024-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subjects over 18 years of age.
• Referred to outpatient arrhythmia clinic with a history of one or more of the following conditions:
• Previous diagnosis of arrhythmia presenting to the clinic for routine follow-up evaluation.
• Patients with symptoms indicative of cardiac arrhythmias.
• Able and willing to sign informed consent.

You may not qualify if…

• Open chest wounds or recent (<30 days) surgery to the chest or abdomen.
• Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol.

Where it is running

• Piedmont Heart Institute — Atlanta, Georgia, United States
• Atlanta Heart Specialists — Tucker, Georgia, United States
• The Mount Sinai Hospital — New York, New York, United States
• Long Island Jewish Medical Center — Queens, New York, United States
• Allegheny Health Network — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.